Sanofi’s 500,000-dose shortfall shifts Korea flu vaccine stocks to NIP
AI Summary- Sanofi-Aventis Korea failed to secure 500,000 contracted NIP vaccine doses.
- 500,000 doses shifted from GC Biopharma’s private-market stock to the NIP.
- KDCA says free vaccinations will proceed from September 21 through April 30, 2027.